Evidence map›Paper›PMID 40404982›Full record

ArticleNature structural & molecular biology2025

Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.

Iga Kucharska, Danton Ivanochko, Sophia Hailemariam, Maartje R Inklaar, Hee Ryung Kim, Karina Teelen, Rianne Stoter, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Anthony Semesi and 6 more

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Iga Kucharska *Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-6150-3419
Danton Ivanochko *Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Sophia Hailemariam *Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Maartje R InklaarDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Hee Ryung KimProgram in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Karina TeelenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Rianne StoterDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Marga van de Vegte-BolmerDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Geert-Jan van GemertDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Anthony SemesiProgram in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Brandon McLeodProgram in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Ahyoung KiStructural Analysis Team, New Drug Development Center, KBIO Osong Medical Innovation Foundation, Osong, Republic of Korea.ORCID http://orcid.org/0009-0003-1512-3660
Won-Kyu LeeStructural Analysis Team, New Drug Development Center, KBIO Osong Medical Innovation Foundation, Osong, Republic of Korea.ORCID http://orcid.org/0000-0003-4040-1100
John L RubinsteinProgram in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-0566-2209
Matthijs M JoreDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-0686-370X
Jean-Philippe JulienProgram in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada. jean-philippe.julien@sickkids.ca.ORCID http://orcid.org/0000-0001-7602-3995

Funding

High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
NIH HHS S10 OD012289
6 · The paper itself

Abstract

Biomedical interventions that block the transmission of Plasmodium falciparum (Pf) from humans to mosquitoes may be critical for malaria elimination. Pfs48/45, a gamete-surface protein essential for Pf development in the mosquito midgut, is a target of clinical-stage transmission-blocking vaccines and monoclonal antibodies (mAbs) that disrupt Pf transmission to mosquitoes. Antibodies directed to domain 3 of Pfs48/45 have been structurally and functionally described; however, in-depth information about other inhibitory epitopes on Pfs48/45 is currently limited. Here, we present a cryo-electron microscopy structure of full-length Pfs48/45 in complex with potent human mAbs targeting all three domains. Our data indicate that although Pfs48/45 domains 1 and 2 are rigidly coupled, there is substantial conformational flexibility between domains 2 and 3. Characterization of mAbs against domain 1 revealed the presence of a conformational epitope class that is largely conserved across Pf field isolates and is associated with recognition by potent antibodies. Our study provides insights into epitopes across full-length Pfs48/45 and has implications for the design of next-generation malaria interventions.

Indexed as

Antibodies, MonoclonalAntibodies, ProtozoanPlasmodium falciparumProtozoan ProteinsAnimalsCryoelectron MicroscopyEpitopesHumansMalaria, FalciparumMembrane GlycoproteinsModels, MolecularProtein ConformationProtein DomainsAntibodies, MonoclonalAntibodies, ProtozoanEpitopesMembrane Glycoproteinspfs48-45 protein, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID40404982
PMCPMC12350152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.